Literature DB >> 10874179

A case of Marchiafava-Bignami disease: MRI findings on spin-echo and fluid attenuated inversion recovery (FLAIR) images.

T Yamamoto1, R Ashikaga, Y Araki, Y Nishimura.   

Abstract

Marchiafava-Bignami disease (MBD) was diagnosed in a 56-year-old man. Spin-echo (SE) magnetic resonance imaging (MRI) at the acute phase showed normal signal areas in the central layer of the corpus callosum (CC), although the intensity of these areas revealed abnormal hyperintensity on fluid attenuated inversion recovery (FLAIR). On follow-up SE MRI at the late phase, the central layer of the CC showed fluid-like intensity. On FLAIR MRI, the lesions of the CC turned into hypointense cores surrounded by hyperintense rims indicating central necrosis and peripheral demyelination. Degenerative changes of the CC in MBD were clearly demonstrated by FLAIR MRI.

Entities:  

Mesh:

Year:  2000        PMID: 10874179     DOI: 10.1016/s0720-048x(99)00125-4

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

1.  Acute Marchiafava-Bignami disease: MR findings in two patients.

Authors:  Andres Arbelaez; Adriana Pajon; Mauricio Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

Review 2.  Clinicoradiologic subtypes of Marchiafava-Bignami disease.

Authors:  Alexander Heinrich; Uwe Runge; Alexander V Khaw
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

3.  Acute Marchiafava-Bignami disease presenting as reversible dementia in a chronic alcoholic.

Authors:  Vineet Sehgal; Praveen Kesav; M Modi; Chirag K Ahuja
Journal:  BMJ Case Rep       Date:  2013-02-15

4.  Focal lesion in the splenium of the corpus callosum on FLAIR MR images: a common finding with aging and after brain radiation therapy.

Authors:  Joseph S Pekala; Alexander C Mamourian; Heather A Wishart; William F Hickey; James D Raque
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.